跳至主要内容
临床试验/NCT04995887
NCT04995887已完成不适用

RUBY: Treating Abnormal Postpartum Uterine Bleeding or Postpartum Hemorrhage With the Jada® System - A Post-Market Registry

Alydia Health16 个研究点 分布在 1 个国家目标入组 809 人开始时间: 2020年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
809
试验地点
16
主要终点
Safety: device-related Adverse Events

研究概览

简要总结

The RUBY Study is a multicenter, observational, post-market registry designed to collect observational data on patients treated with the Jada System in the post-market setting.

详细描述

The purpose of this registry is to collect observational data on patients treated with the Jada System in the post-market setting. Data collection will include observations of effectiveness and safety of the device. Additional outcome data related to resource utilization will also be included.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

性别
Female
接受健康志愿者

入选标准

  • Use of the Jada System (inserted into the patient and connected to vacuum).
  • NOTE: There is no Exclusion Criteria in this protocol.

排除标准

  • 未提供

结局指标

主要结局

Safety: device-related Adverse Events

时间窗: 24 hours through time of discharge.

Rates of procedure- and device-related adverse events.

Efficacy: Cessation of PPH

时间窗: 24 hours

Proportion of patients with atony-related abnormal postpartum uterine bleeding or PPH successfully treated with the Jada System. Treatment success is defined as the avoidance of escalated non-surgical or surgical intervention to control abnormal postpartum uterine bleeding or PPH after the Jada System was used. Note: Concomitant treatment with uterotonics or uterine compression sutures does not constitute escalation (i.e., failure). However, if the Jada treatment was aborted to instead administer treatment with compression sutures for ongoing bleeding, then the event does meet the escalation (i.e., failure) definition.

次要结局

  • Transfusion rates(24 hours through time of discharge.)
  • Length of stay(24 hours through time of discharge.)
  • Time spent in care settings(24 hours through time of discharge.)
  • Rate of non-surgical or surgical procedures other than Jada(24 hours)
  • In-dwelling time of Jada during treatment(24 hours)

研究者

发起方
Alydia Health
申办方类型
Industry
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验